Cited by

• CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.

  Sorrentino C, D'Antonio L, Ciummo SL, Fieni C, Landuzzi L, Ruzzi F, Vespa S, Lanuti P, Lotti LV, Lollini PL, Di Carlo E. Sorrentino C, et al. J Hematol Oncol. 2022 Oct 13;15(1):145. doi: 10.1186/s13045-022-01357-6. J Hematol Oncol. 2022. PMID: 36224639 Free PMC article.
• Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.

  Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N. Poulaki V, et al. Am J Pathol. 2002 Aug;161(2):643-54. doi: 10.1016/S0002-9440(10)64220-4. Am J Pathol. 2002. PMID: 12163389 Free PMC article.
• Insulinlike growth factor-1Ec (MGF) expression in eutopic and ectopic endometrium: characterization of the MGF E-peptide actions in vitro.

  Milingos DS, Philippou A, Armakolas A, Papageorgiou E, Sourla A, Protopapas A, Liapi A, Antsaklis A, Mastrominas M, Koutsilieris M. Milingos DS, et al. Mol Med. 2011 Jan-Feb;17(1-2):21-8. doi: 10.2119/molmed.2010.00043. Epub 2010 Sep 14. Mol Med. 2011. PMID: 20844834 Free PMC article.
• Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis.

  Al-Husein B, Goc A, Somanath PR. Al-Husein B, et al. J Cell Physiol. 2013 Nov;228(11):2139-48. doi: 10.1002/jcp.24381. J Cell Physiol. 2013. PMID: 23559257 Free PMC article.
• Immunohistochemical expression of insulin-like growth factor-1Ec in primary endometrial carcinoma: Association with PTEN, p53 and survivin expression.

  Stavropoulos A, Varras M, Philippou A, Vasilakaki T, Varra VK, Varra FN, Tsavari A, Lazaris AC, Koutsilieris M. Stavropoulos A, et al. Oncol Lett. 2020 Dec;20(6):395. doi: 10.3892/ol.2020.12258. Epub 2020 Oct 29. Oncol Lett. 2020. PMID: 33193855 Free PMC article.